Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
alkermes
allergan
author_name|malak saleh
biotech
boston blog main
boston top stories
buprenorphine
cariprazine
clinical trials
eli lilly
europe
europe blog main
europe top stories
fda
felipe jain
health
health care industry
jess fiedorowicz
jessica jeffrey
karim calis
language|en-us
life sciences
lumateperone
m health fairview
marc goodman
massachusetts general hospital
national blog main
national institutes of health (nih)
national top stories
olanzapine
opioid
ottawa hospital
pharmaceuticals & drug trials
provider_name|engadget
region|us
samidorphan
site|engadget
steven meisel
svb leerink
What
effect
3
×
fda
3
×
drug
medicine
panel
alkermes
antipsychotic
approved
begin
benefits
biosimilar
caveats
cheaper
cnet
cold
collaborate
commercialize
commonly
cordavis
cvs
decongestant
designed
drugs
existing
favor
feeling
gain
health
identical
ineffective
know
launching
manufacturers
manufacturing
markets
medications
near
new
offer
phenylephrine
Language
unset
Current search:
effect
×
fda
×
@cnet.com
7 months ago
Your Decongestant Might Not Work, but Don't Throw Out Your Cold Medicine Yet - CNET
@engadget.com
8 months ago
CVS Health will begin manufacturing cheaper 'biosimilar' drugs
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats